ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) saw a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 2,200 shares, a decrease of 43.6% from the December 31st total of 3,900 shares. Based on an average trading volume of 11,000 shares, the short-interest ratio is presently 0.2 days.
ProShares Ultra Nasdaq Biotechnology Price Performance
Shares of NASDAQ BIB traded up $1.19 during midday trading on Thursday, reaching $56.01. The company’s stock had a trading volume of 6,411 shares, compared to its average volume of 8,543. The firm has a 50 day moving average price of $54.20 and a 200-day moving average price of $60.49. ProShares Ultra Nasdaq Biotechnology has a 12-month low of $47.19 and a 12-month high of $69.56.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
The business also recently declared a dividend, which was paid on Tuesday, December 31st. Investors of record on Monday, December 23rd were issued a $0.3964 dividend. The ex-dividend date was Monday, December 23rd. This is a boost from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15.
Institutional Investors Weigh In On ProShares Ultra Nasdaq Biotechnology
About ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
See Also
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Using the MarketBeat Stock Split Calculator
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How Can Investors Benefit From After-Hours Trading
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.